Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
Supernus Pharmaceuticals (SUPN) Ownership Overview
4.33% Insiders
35.27% Mutual Funds
24.90% Other Institutional Investors
26.71% ETFs
8.78% Public Companies and
Individual Investors
The ownership structure of Supernus Pharmaceuticals (SUPN) stock is a mix of institutional, retail, and individual investors. Approximately 86.89% of the company’s stock is owned by Institutional Investors, 4.33% is owned by Insiders, and 8.78% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 16, 2026 | xxxxxxxxxxxxx | $271725 | |
Mar 10, 2026 | xxxxxxxxxxxxx | $87074 | |
Mar 10, 2026 | xxxxxxxxxxxxx | $483797 | |
Mar 09, 2026 | xxxxxxxxxxxxx | $1002811 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $9827528 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,467,814 | Institution | 11.23% | 318,798,552 | |
| 5,729,042 | Institution | 9.95% | 282,384,480 | |
| 5,155,865 | Institution | 8.95% | 254,132,586 | |
| 4,331,357 | Institution | 7.52% | 213,492,587 | |
| 2,199,244 | Insider | 3.82% | 108,400,737 | |
| 1,714,841 | Institution | 2.98% | 84,524,513 | |
| 1,263,811 | Institution | 2.19% | 62,293,244 | |
| 1,108,972 | Institution | 1.93% | 54,661,230 | |
| 718,707 | Institution | 1.25% | 35,425,068 | |
| 670,816 | Institution | 1.16% | 33,064,521 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,729,042 | Institution | 9.95% | 282,384,480 | |
| 4,331,357 | Institution | 7.52% | 213,492,587 | |
| 1,714,841 | Institution | 2.98% | 84,524,513 | |
| 718,707 | Institution | 1.25% | 35,425,068 | |
| 610,365 | Institution | 1.06% | 30,084,891 | |
| 551,590 | Institution | 0.96% | 27,187,871 | |
| 510,279 | Institution | 0.89% | 25,151,652 | |
| 388,486 | Institution | 0.67% | 19,148,475 | |
| 375,471 | Institution | 0.65% | 18,506,966 | |
| 358,847 | Institution | 0.62% | 17,687,569 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,485,380 | Institution | 6.05% | 171,794,380 | |
| 1,720,140 | Institution | 2.99% | 94,143,262 | |
| 1,349,911 | Institution | 2.34% | 66,537,113 | |
| 1,237,009 | Institution | 2.15% | 67,701,503 | |
| 794,508 | Institution | 1.38% | 43,483,423 | |
| 624,769 | Institution | 1.09% | 34,193,607 | |
| 534,976 | Institution | 0.93% | 26,368,967 | |
| 429,045 | Institution | 0.75% | 21,147,628 | |
| 337,005 | Institution | 0.59% | 16,610,976 | |
| 278,581 | Institution | 0.48% | 13,731,257 |
FAQ
Who Owns Supernus Pharmaceuticals (SUPN)?
According to the latest TipRanks data, approximately 24.90% of the company's stock is held by institutional investors, 4.33% is held by insiders, and 8.78% is held by retail investors.
What percentage of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.90% of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors.
What percentage of Supernus Pharmaceuticals (SUPN) stock is held by retail investors?
According to the latest TipRanks data, approximately 8.78% of Supernus Pharmaceuticals (SUPN) stock is held by retail investors.
Who owns the most shares of Supernus Pharmaceuticals (SUPN)?
iShares owns the most shares of Supernus Pharmaceuticals (SUPN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.